View More
Should patients with advanced HIV disease be started on INSTI-based regimens?
What do the latest clinical data show about giving rifampin with dolutegravir, bictegravir, or tenofovir alafenamide?
Annenberg Center for Health Sciences at Eisenhower
39000 Bob Hope Dr
Dinah Shore Bldg.
Rancho Mirage, CA 92270
Melissa Velasquez, Accreditation Specialist
(760) 773-4506
(760) 773-4550 (Fax)
ce@annenberg.net
http://www.annenberg.net/
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.